Literature DB >> 5332286

The effects of long-term acetohexamide treatment on pancreatic islet cell function in maturity-onset diabetes.

J Sheldon, K W Taylor, J Anderson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5332286     DOI: 10.1016/0026-0495(66)90158-2

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  20 in total

1.  Treatment of type II diabetes.

Authors:  M Nattrass
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-19

Review 2.  Insulin and oral hypoglycaemic agents. I. Physiological and clinical pharmacological aspects.

Authors:  H D Breidahl; G C Ennis; F I Martin; J R Stawell; P Taft
Journal:  Drugs       Date:  1972       Impact factor: 9.546

3.  [Investigations of the effects of diet, tolbutamide and buformin and their combination on body weight and several metabolic parameters in diabetics. I. Body weight, carbohydrate metabolism and immunoreactive insulin].

Authors:  A Appels; R Kattermann; H Proschek; K Hubrich; H Frerichs; H D Söling; W Creutzfeldt
Journal:  Diabetologia       Date:  1968-08       Impact factor: 10.122

4.  Glucose tolerance, plasma insulin and lipids in diabetic subjects before and after treatment with a new sulfonylurea compounds, Ro 6-4563.

Authors:  P Berchtold; P Björntorp; A Gustafson; A Jonsson; S E Fagerberg
Journal:  Eur J Clin Pharmacol       Date:  1971-12       Impact factor: 2.953

5.  The normal insulin response to glucose. The relationship between blood sugar and plasma insulin.

Authors:  K D Buchanan; M T McKiddie
Journal:  Diabetologia       Date:  1967-10       Impact factor: 10.122

6.  Glucose and insulin after diet and tolazamide treatment.

Authors:  J Sheldon
Journal:  Br Med J       Date:  1970-10-24

Review 7.  The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.

Authors:  R E Ferner; S Chaplin
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

Review 8.  Oral hypoglycaemic agents. An update.

Authors:  A C Asmal; A Marble
Journal:  Drugs       Date:  1984-07       Impact factor: 9.546

9.  The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects.

Authors:  J D Bagdade; E L Bierman; D Porte
Journal:  J Clin Invest       Date:  1967-10       Impact factor: 14.808

10.  Clinical and metabolic study in diabetic patients treated with glibenclamide.

Authors:  J Anderson; R Coulson; B D Grassick; B A Morris; W D Thomas; R W Tomlihson; F Woodroffe
Journal:  Br Med J       Date:  1970-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.